Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107) (Q82498689)
Jump to navigation
Jump to search
scientific article published on 15 November 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107) |
scientific article published on 15 November 2011 |
Statements
Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107) (English)
Livio Pagano
Emanuele Ammatuna
Paola Fazi
Monia Lunghi
Giovanni Martinelli
Giovanna Meloni
Daniela Cilloni
Luciana Annino
Roberto Stasi
Alberto M Martelli
Fabrizio Pane
Elena Rossetti
Claudio Fozza
Francesca Ricci
Edoardo La Sala
15 November 2011